Accolade Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

7 analysts have expressed a variety of opinions on Accolade ACCD over the past quarter, offering a diverse set of opinions from bullish to bearish.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $15.29, a high estimate of $17.00, and a low estimate of $12.00. This upward trend is evident, with the current average reflecting a 15.83% increase from the previous average price target of $13.20.

Analyzing Analyst Ratings: A Detailed Breakdown

The standing of Accolade among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Accolade. This information offers a snapshot of how analysts perceive the current state of the company.
• Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Accolade compared to the broader market.
• Price Targets: Gaining insights, analysts provide estimates for the future value of Accolade's stock. This comparison reveals trends in analysts' expectations over time.

Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Accolade's market position. Stay informed and make well-informed decisions with our Ratings Table.

Stay up to date on Accolade analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

All You Need to Know About Accolade

Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members.

A Deep Dive into Accolade's Financials

Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.

Revenue Growth: Accolade's remarkable performance in 3 months is evident. As of 30 November, 2023, the company achieved an impressive revenue growth rate of 9.26%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.

Net Margin: Accolade's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -21.2%, the company may face hurdles in effective cost management.

Return on Equity (ROE): Accolade's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -4.83%, the company may encounter challenges in delivering satisfactory returns for shareholders.

Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -2.57%, the company may need to address challenges in generating satisfactory returns from its assets.

Debt Management: Accolade's debt-to-equity ratio is below the industry average. With a ratio of 0.56, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

Analyst Ratings: What Are They?

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

This article was generated by Benzinga's automated content engine and reviewed by an editor.